RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$80.11
+9.47%Forward multiples
Based on analyst estimates
- P/E forward
- 119.91x
- P/E 2026E
- 154.08x
- P/E 2027E
- 88.54x
- P/E 2028E
- 71.39x
- P/S forward
- 2.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.75x
- Price / sales
- 2.78x
- Price / cash flow
- 19.89x
Enterprise value
- Enterprise value
- $8.1B
- EV / sales
- 3.55x
- EV / EBITDA
- 29.05x
- EV / EBIT
- 88.71x
- Market cap
- $6.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026